Eveline Trachsel
About Eveline Trachsel
Eveline Trachsel is the Medical Director for Switzerland and Austria at Bristol-Myers Squibb, with a background in clinical research and therapeutic protein research.
Current Position at Bristol-Myers Squibb
Eveline Trachsel has been serving as the Medical Director for Switzerland and Austria at Bristol-Myers Squibb since September 2018. In this role, she oversees medical strategies and operations in these regions, contributing to the company's initiatives in innovative healthcare solutions.
Past Role at Dana-Farber Cancer Institute
Eveline Trachsel worked at Dana-Farber Cancer Institute in Boston, Massachusetts, as a Clinical Research Manager from 2012 to 2015. During her three years at the institute, she was responsible for managing clinical research projects and ensuring they adhered to regulatory and ethical standards.
Background in Scientific Consultancy at Philochem AG
Eveline Trachsel served as a Scientific Consultant at Philochem AG in Boston, Massachusetts, from 2011 to 2012. In this role, she provided expertise in therapeutic protein research and contributed to the development of scientific strategies.
Head of Therapeutic Protein Research at Philochem AG
Eveline Trachsel held the position of Head of Therapeutic Protein Research and was a member of the board at Philochem AG from 2006 to 2011. Her responsibilities included leading research projects focused on therapeutic proteins and participating in strategic decision-making at the board level.
Ph.D. and Education at ETH Zurich
Eveline Trachsel completed her Ph.D. at ETH Zurich from 2002 to 2006, focusing on an unspecified area of study. She also earned her Masters at ETH Zurich, studying from 1996 to 2001. Her academic background laid the foundation for her career in clinical research and medical direction.